Author

James Lindsay 1

1 Department of Gastroenterology,Barts Health NHS Trust,London,United Kingdom

INDICATORS OF SUBOPTIMAL THERAPY AMONG CROHN’S DISEASE PATIENTS TREATED WITH TUMOR NECROSIS FACTOR ANTAGONISTS: RESULTS FROM A MULTINATIONAL STUDY

Alessandro Armuzzi, James Lindsay, Reema Mody, Bernd Bokemeyer, Javier Gisbert, Laurent Peyrin-Biroulet, Geoffrey C. Nguyen, Jean Siebenaler, Örjan Åkerborg, Michael Smyth

INTERLEUKIN-17A HOMODIMER REDUCES PRO-INFLAMMATORY CYTOKINE PRODUCTION BY INFLAMMATORY BOWEL DISEASE MUCOSA CULTURED EX VIVO

Paolo Biancheri, Antonio Di Sabatino, Renata Curciarello, Paolo Giuffrida, Francesca Ammoscato, Gino Corazza, James Lindsay, Thomas Thornton MacDonald

Management of early Crohn's disease: Immunosuppression!

James Lindsay

Norgine - Lightening the load of iron deficiency anaemia in inflammatory bowel disease

Silvio Danese, Fernando Gomollon Garcia, Stefanie Howaldt, James Lindsay

Panel discussion

Geert R. D'Haens, Paul Moayyedi, James Lindsay, Gerassimos J. Mantzaris, Gianluca Ianiro

PREDICTORS OF NON-RESPONSE OR LOSS OF RESPONSE TO TUMOUR NECROSIS FACTOR ANTAGONIST THERAPIES IN INFLAMMATORY BOWEL DISEASE

Laurent Peyrin-Biroulet, Alessandro Armuzzi, Javier Gisbert, Geoffrey C. Nguyen, Bernd Bokemeyer, James Lindsay, Michael Smyth, Melvin Munsaka, Sreeram Ramagopalan, Javaria Mona Khalid

Preventive and screening measures

James Lindsay

PROFILING OF SERUM MICRORNA IDENTIFIES NOVEL BIOMARKERS OF FIBROSTENOSING CROHN’S DISEASE.

Amy Lewis, Luke Hanna, Laura Rogalski, Shameer Mehta, Paolo Biancheri, Jacob Bundy, Cleo Bishop, Antonio Di Sabatino, James Lindsay

Refractory perianal fistulising disease: The gastroenterologist's view & The surgeon's view

Carolynne Vaizey, James Lindsay

RESPONDERS TO HAEMOPOIETIC STEM CELL TRANSPLANTATION FOR CROHN’S DISEASE

Christopher John Hawkey, Matthieu Allez, Miranda Clark, Myriam Labopin, James Lindsay, Elena Ricart, Gerhard Rogler, Jack Satsangi, Philip Kaye, Caroline Sharratt, Dominique Farge

Item 11 - 20 / 48
1
2
3 4 5